Effects of Glucagon-Like Peptide 1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-analysis.
胰高血糖素樣肽 1 受體激動劑對心房顫動在導管消融後復發的影響:系統性回顧與統合分析。
Adv Ther 2024-08-14
Glucagon-Like Peptide-1 Protects Against Atrial Fibrillation and Atrial Remodeling in Type 2 Diabetic Mice.
葡萄糖樣肽-1在第2型糖尿病小鼠中對心房顫動和心房重塑具有保護作用。
JACC Basic Transl Sci 2023-09-19
Impact of Sodium-Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With Diabetes: A Propensity-Score Matching Study and Meta-Analysis.
葡萄糖鈉共轉運輸蛋白2抑制劑對糖尿病患者房顫射頻消融術後復發的影響:傾向性配對研究和荟萃分析。
J Am Heart Assoc 2024-02-15
Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study.
糖尿病成人中胰高血糖素樣肽-1受體激動劑與房顫風險:一項真實世界研究。
J Gen Intern Med 2024-01-23
Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials.
GLP-1 受體激動劑在肥胖或超重患者中的心血管益處:隨機對照試驗的荟萃分析。
Am J Cardiovasc Drugs 2024-05-15
Semaglutide for the prevention of atrial fibrillation: A systematic review and meta-analysis.
Semaglutide用於預防心房纖維顫動:系統性回顧與荟萃分析。
Diabetes Metab Syndr 2024-07-02
Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence after Catheter Ablation in Type 2 Diabetes Mellitus: A Meta-Analysis of Reconstructed Kaplan-Meier Curves with Trial Sequential Analysis.
SGLT2 抑制劑對第二型糖尿病患者導管消融後心房纖維顫動復發的影響:重建 Kaplan-Meier 曲線的 Meta 分析與試驗序列分析。
Am J Cardiovasc Drugs 2024-07-04
Impact of Sodium-glucose Cotransporter 2 Inhibitor on Recurrence and Cardiovascular Outcomes after Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure.
鈉-葡萄糖共轉運蛋白 2 抑制劑對心衰竭患者經導管消融治療心房顫動後復發及心血管結果的影響。
Heart Rhythm 2024-08-21